rawfin.tv
Citizens Reiterates MacroGenics Market Perform Rating Ahead of ESMO 2026 Data
MarketsstocksAI Generated

Citizens Reiterates MacroGenics Market Perform Rating Ahead of ESMO 2026 Data

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Citizens has reaffirmed its Market Perform rating for MacroGenics Inc. (NASDAQ:MGNX) in anticipation of the upcoming ESMO 2026 conference. Investors are awaiting new data from the event, which could impact the stock.

biotechanalyst ratingESMOclinical data

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks